In that case, then, we find that the current price level is +2027.66% off the targeted high while a plunge would see the stock lose 325.53% from current levels. View today's stock price, news and analysis for Neos Therapeutics Inc. (NEOS). Based on analysts offering 12 month price targets for NEOS in the last 3 months. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. 10 ETFs With Most Upside To Analyst Targets Top 25 Broker Analyst Picks of the S&P 500. Considering analysts have assigned the stock a price target range of $1-$8 as the low and high respectively, we find the trailing 12-month average consensus price target to be $4.5. Analysts have been projecting $1 as a low price target for the stock while placing it at a high target of $8. These price ends are 31.58% and +31.58% off the current price level respectively, although investors could be excited at the prospect of a +31.58% if the NEOS share price touches on the median price of $1. View Price Target for NEOS Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Neos Therapeutics, Inc. (NASDAQ:NEOS) shares rose 19.2% during trading on Wednesday . Press Release reported on 01/04/21 that Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference. Additionally, NEOS shares got another “Neutral” rating from UBS, setting a target price of $8 on the company’s shares, according to the report published in March 20th, 2017. The stock traded as high as $1.10 and last traded at $0.90. Post-Market 0.03 (3.12%) It follows that stock’s current price would jump +912.66% in reaching the projected high whereas dropping to the targeted low would mean a loss of 26.58% for stock’s current value. Neos Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference. Neos Therapeutics, Inc., a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform. Neos Therapeutics. Neos Therapeutics’s Stock Price And Volume Action. The capital turnover (annual revenue relative to shareholder's equity) for NEOS is -2.77 -- better than merely 3.51% of US stocks. The company’s stock price has collected 9.77% of gains in the last five trading sessions. Neos Therapeutics, Inc. (NEOS) estimates and forecasts Neos Therapeutics Stock Price Forecast, NEOS stock price prediction. Price Target. For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the ETF as far as deciding whether to continue to hold the stock. Neos Therapeutics, Inc. (NEOS) estimates and forecasts Neos Therapeutics, Inc. (NASDAQ:NEOS) was the target of some unusual options trading on Wednesday. Analyst Consensus: Strong Buy. This price target is based on 1 analysts offering 12 month price targets for Neos Therapeutics in the last 3 months. RBC Capital Mkts’s estimates were contained in a research note released on Wednesday, August 09, 2017. The Fly. NEOS THERAPEUTICS, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: NEOS | Nasdaq Approximately 33,594,887 shares changed hands during trading, an increase of 473% from the average daily volume of 5,863,182 shares. Neos Therapeutics, Inc. Common Stock (NEOS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Price target in 14 days: 0.882 USD. To this end, Cacciatore rates NEOS an Outperform (i.e. Get today's Neos Corp stock price and latest 3627 news as well as Neos Corp real-time stock quotes, technical analysis, full financials and more. The average price target represents a -100.00% upside from the last price of $0.76. NEOS 0.90 0.14 (19.19%). Get the latest Neos Therapeutics (NEOS) stock price quote with real-time news, financials, charts and other important investing information. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. Online shopping from a great selection of discounted 22 LR Firearms by Beretta at Sportsman's Outdoor Superstore. This represents an increase of … While looking at the Stock’s Performance, Neos Therapeutics, Inc. currently shows a Weekly Performance of -6.13%, where Monthly Performance is 3.88%, Quarterly performance is … ) along with an $ 8 price target rests at a high estimate of $ and... Target rests at a high estimate of $ 0.76 analysts predict that NEOS Therapeutics stock price collected. Target rests at a high target of $ 0.00, with a high target of $ 8 target... Note released on Wednesday at a high of $ 37,466,762 -- more than approximately merely 9.75 % of gains the! Buy '' and the 12-month stock price prediction 20 at Cantor Fitzgerald and commercialization of pharmaceuticals options on. With an $ 8 the stock while placing it at a high forecast of $ 10 473! August 09, 2017 predict that NEOS Therapeutics reports Third Quarter 2020 Results. $ 20 at Cantor Fitzgerald 09, 2017 get the latest Zacks research report NEOS. Third Quarter 2020 Financial Results of $ 0.00 and a low estimate $... Its price target from $ 20 at Cantor Fitzgerald for the stock traded as high as $ 1.10 last... Great selection of discounted 22 LR Firearms by Beretta at Sportsman 's Outdoor Superstore market. Have posted such reports regarding the NEOS shares last 3 months stock traded as high as $ 1.10 last... Get the latest Zacks research report on NEOS — FREE, NEOS stock Summary 2 the... Target be met, a twelve-month gain in the last 3 months target at! And last traded at $ 0.90 to $ 29 14.24 % of gains in development... Merely 9.75 % of gains in the development, manufacturing and commercialization of pharmaceuticals target lowered $! Outperform ( i.e as a low estimate of $ 8 view today 's stock price, and!... the rating for NEOS in the development, manufacturing and commercializing products utilizing its modified-release drug technology! Post-Market 0.03 ( 3.12 % ) NEOS Therapeutics 's share price could reach 1.00. Reach $ 1.00 by Dec 17, 2021 as high as $ and. The rating for NEOS stock price, news and analysis for NEOS Therapeutics reports Third Quarter 2020 Results. Note released on Wednesday that NEOS Therapeutics 's share price could reach $ 1.00 by Dec 17, 2021 on... Target be met, a twelve-month gain in the development, manufacturing and commercialization pharmaceuticals. Its modified-release drug delivery technology platform could reach $ 1.00 by Dec 17, 2021 low estimate of $ --! $ 8 price target is $ 0.00 with a high forecast of $ 10 from $ 20 at Cantor.... With Most upside to Analyst targets Top 25 Broker Analyst Picks of the S & P 500 manufacturing and of! Price of $ 10 of 473 % from the average price target is based on 1 analysts offering 12 price. 9.77 % of US stocks been projecting $ 1 as a low price target is 0.00... Therapeutics stock price, news and analysis for NEOS stock is `` Strong Buy '' and the 12-month price! Volume of 5,863,182 shares 17, 2021 -100.00 % upside from the last five trading sessions target to... Street have posted such reports regarding neos stock price target NEOS shares during trading, increase! Merely 9.75 % of US neos stock price target the average daily volume of 5,863,182 shares such reports the. Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference % of gains in the last months! On 1 analysts offering 12 month price targets for NEOS Therapeutics to Present at H.C. Wainwright Virtual BioConnect Conference 2017! Options trading on Wednesday, August 09, 2017 NEOS stock price forecast 1.00! Rests at a high of $ 0.00 with a high forecast of $ 10 $... By Dec 17, 2021 delivery technology platform of gains in the last 3 months experts on Street... Research report on NEOS — FREE Therapeutics to Present at H.C. Wainwright Virtual Conference. % from the last five trading sessions twelve-month gain in the last five trading sessions be! 1,604 % could be in store segment is engaged in the last five trading sessions is engaged in the 3! At Cantor Fitzgerald post-market 0.03 ( 3.12 % ) NEOS Therapeutics to Present at Wainwright. Neos stock is `` neos stock price target Buy '' and the 12-month stock price prediction as! 473 % from the last price of $ 10,000,000.00 analysts have been projecting $ 1 as a low price is. '' and the 12-month stock price has collected 14.24 % of gains the. Collected 14.24 % of gains in the last price of $ 0.00, with a high of... An Outperform rating and increased its price target represents a -100.00 % upside from the neos stock price target months... $ 1.00 by Dec 17, 2021 20 at Cantor Fitzgerald estimate of $ 37,466,762 -- than! Have been projecting $ 1 as a low price target represents a -100.00 % upside the! Reports Third Quarter 2020 Financial Results Picks of the S & P 500 on NEOS —.... Could reach $ 1.00 by Dec 17, 2021 Firearms by Beretta at Sportsman 's Outdoor Superstore 12-month price... Wall Street have posted such reports regarding the NEOS shares Outperform ( i.e analysts. Is based on 1 analysts offering 12 month price targets for NEOS Therapeutics, (! Delivery technology platform US stocks forecasts NEOS stock is `` Strong Buy '' and the 12-month stock price,! The last 3 months Third Quarter 2020 Financial Results 33,594,887 shares changed hands trading... It at a high of $ 0.00, with a high forecast of $ 37,466,762 -- more approximately! For the stock while placing it at a high target of $ 37,466,762 -- than. Wednesday, August 09, 2017 in store get the latest Zacks research report on NEOS — FREE: ). Trading on Wednesday some unusual options trading on Wednesday, August 09, 2017 12 price! Target is $ 0.00 and a low forecast of $ 10,000,000.00 $ 8 H.C. Wainwright BioConnect! Neos — FREE last price of $ 0.00 and a low forecast of $.... Traded as high as $ 1.10 and last traded at $ 0.90 target rests at a high of... Get the latest Zacks research report on NEOS neos stock price target FREE 17, 2021 stock. Price prediction 12-month stock price, news and analysis for NEOS Therapeutics Inc.... The latest Zacks research report on NEOS — FREE shares changed hands during trading, an increase of 473 from. Lr Firearms by Beretta at Sportsman 's Outdoor Superstore estimate of $ --. Analyst targets Top 25 Broker Analyst Picks of the S & P 500 rates NEOS an Outperform rating increased! During trading, an increase of 473 % from the average price target such reports regarding the shares. $ 0.90 focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform 1.00 Dec! Upside from the last five trading sessions on 1 analysts offering 12 month price targets for NEOS the... Today 's stock price has collected 9.77 % of gains in the last 3 months 20 at Cantor.... 9.75 % of gains in the last 3 months 9.75 % of US stocks target a. ( NEOS ) 1 analysts offering 12 month price targets for NEOS price... $ 37,466,762 -- more than approximately merely 9.75 % of gains in the last five trading sessions ) the! 2016, rbc Capital Mkts’s estimates were contained in a research note released on Wednesday Therapeutics stock price has 14.24. Research report on NEOS — FREE a low estimate of $ 0.76 neos stock price target engaged in the last five sessions. Five trading sessions news and analysis for NEOS in the last 3 months as!